|
|
|
|
|
After the very successful previous conferences in Europe and USA , the EORTC-NCI-AACR Conference has become an unique and internationally recognized forum for the exchange of information on advances in early drug development in the treatment of cancer. This 18th conference is organized by the European Organization for Research and Treatment of Cancer (EORTC) in conjunction with the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), in Prague , 7 – 10 November 2006.
The programme will cover the entire spectrum of early drug development. Special attention will be given to the preclinical/clinical interphase discussing preclinical and Phase I trials. The conference has been designed to ensure maximum interaction and discussion between scientists, clinicians and those involved in drug development. Due to the popularity of the conference, the attendance has been limited to 2200 participants.
Early registration: 1 June 2006
Late registration: 16 Oct 2006
Abstract submission: 12 June 2006
Advance programme: Available 1st November 2005.
PRAGUE CONGRESS CENTRE
5 kvetna 65,
CZ-140 21 Prague 4
Czech Republic
Tel.: +420 261 171 111
Fax: +420 261 222 062
E-mail: kcpinfo@kcp.cz
http://www.kcp.cz
EORTC would like to thank the following companies for their sponsorship to the 18th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics"
will also be available on:
EORTC-NCI-AACR Conference secretariat
Federation of European Cancer Societies
Avenue E. Mounier 83
B-1200 Brussels
Tel.: +32 (0)2 775 02 01
Fax: +32 (0)2 775 02 00
E-mail: ENA2006@fecs.be